NANOG and nonpapillary renal cell carcinoma: In addition to OCT4, the mRNA expression and nuclear localization of Nanog, a downstream target of OCT4 [34], were also suppressed by penfluridol treatment in ccRCC cells (Supplementary Fig. 6).